VolitionRx Ltd Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Tables)

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2013

Patents amortized over their remaining lives

The patents are being amortized over their remaining lives, which are 12 years and 19 years.

					December 31,
					2012
			Accumulated		Net Carrying
	Cost		Amortization		Value
	$		$		$

Patents		1,666,346		236,108		1,430,238

		1,666,346		236,108		1,430,238

					March 31,
					2013
			Accumulated		Net Carrying
	Cost		Amortization		Value
	$		$		$

Patents		1,631,432		258,075		1,373,358

		1,631,432		258,075		1,373,358

Annual estimated amortization schedule

The annual estimated amortization schedule over the next five years is as follows:

2013	$	85,792
2014	$	114,389
2015	$	114,389
2016	$	114,389
2017	$	114,389

- Definition

Tabular disclosure of the activity in the balance of servicing assets subsequently measured at amortized value (including a description of where changes in carrying value are reported in the statement of income for each period for which results of operations are presented), including but not limited to, the following: beginning and ending balances, additions (through purchases of servicing assets and servicing assets that result from transfers of financial assets), disposals, amortization, application of valuation allowances, other-than-temporary impairments, and other changes that affect the balance along with a description of those changes.

+ References + Details